Prostate cancer screening is a controversial topic. We examined trends in Prostate Specific Antigen (PSA) testing in an underserved population before and after the United States Preventative Services Task Force (USPSTF) recommendation against screening. Data were collected on all PSA and cholesterol screening tests from 2008 to 2014.
View Article and Find Full Text PDF